Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03191916 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcranial Direct Current Stimulation for Cognitive Improvement in Parkinson's Patients

Study acronym: tDCS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 4, 2025 (before its estimated August 7, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    • Study title shortened, about 1 word
    v8
  2. Primary completion date: Aug 7, 2023 to Aug 7, 2025
    • Study completion date: Aug 31, 2023 to Aug 31, 2025
    • Site contact updated
    • Study title shortened, about 2 words
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Jul 31, 2020 to Aug 7, 2023
    • Study completion date: Jul 31, 2020 to Aug 31, 2023
    • Site contact updated
    v5
  5. Primary and study completion dates: Feb 27, 2019 to Jul 31, 2020v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary and study completion dates: Feb 27, 2018 to Feb 27, 2019v3
  2. Site contact updatedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left dorsolateral prefrontal cortex (LDLPFC) will induce long-lasting effects in improving cognitive function and reducing cognitive fatigue and fatigability in PD patients.
Trial Details
NCT Number NCT03191916
Lead Sponsor Sanford Health
Conditions
(from sponsor)		 Parkinson Disease
Related terms Parkinson Disease
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov